Valuation: DexCom, Inc.

Market Cap 27.07B 140B 23.78B 21.91B 20.5B 38.42B 2,552B 39.24B 263B 102B 1,260B 102B 99.4B 4,376B P/E 2026 *
28.7x
P/E 2027 * 24x
Enterprise Value 26.66B 138B 23.42B 21.58B 20.2B 37.84B 2,514B 38.65B 259B 100B 1,241B 100B 97.92B 4,311B EV / Sales 2026 *
5.1x
EV / Sales 2027 * 4.43x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day+1.82%
1 week-3.06%
Current month-1.89%
1 month+0.41%
3 months+4.90%
6 months-2.54%
Current year-2.80%
1 week 7.11
Extreme 7.11
7.59
1 month 6.96
Extreme 6.96
8.14
Current year 5.75
Extreme 5.75
8.14
1 year 5.75
Extreme 5.75
10.06
3 years 5.75
Extreme 5.75
14.45
5 years 5.75
Extreme 5.75
18.3
10 years 5.75
Extreme 5.75
18.3
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+1.82%-3.06% - - 27.07B
+0.94%+6.46%-29.96%-12.68% 164B
+1.48%+2.07%-5.86%-7.08% 104B
-0.29%+5.26%-4.44%+51.57% 55.67B
-2.09%-6.13%+51.65%+53.01% 52.92B
+3.00%+8.29%-8.74%-39.62% 42.96B
+2.91%+8.15% - - 32.87B
+1.24%+6.98%+60.30%-5.01% 24.79B
+2.41%+6.45%-9.68%-0.53% 21.02B
+0.84%-0.56%-17.51%-2.75% 20.18B
Average +1.14%+4.14%+4.47%+4.61% 57.56B
Weighted average by Cap. +0.84%+4.21%-5.09%+2.00%

Financials

2026 *2027 *
Net sales 5.22B 27.01B 4.59B 4.23B 3.96B 7.42B 493B 7.58B 50.81B 19.68B 243B 19.62B 19.19B 845B 5.83B 30.14B 5.12B 4.72B 4.42B 8.27B 550B 8.45B 56.7B 21.95B 271B 21.89B 21.41B 943B
Net income 963M 4.98B 846M 779M 729M 1.37B 90.77B 1.4B 9.36B 3.63B 44.8B 3.61B 3.54B 156B 1.16B 5.99B 1.02B 937M 877M 1.64B 109B 1.68B 11.26B 4.36B 53.89B 4.35B 4.25B 187B
Net Debt -405M -2.09B -356M -328M -307M -575M -38.2B -587M -3.94B -1.53B -18.85B -1.52B -1.49B -65.49B -1.21B -6.26B -1.06B -981M -918M -1.72B -114B -1.76B -11.78B -4.56B -56.38B -4.55B -4.45B -196B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
24/06/26 R$7.280 +1.82% 110
23/06/26 R$7.150 +0.56% 105
22/06/26 R$7.110 -5.33% 213
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
70.14USD
Average target price
85.24USD
Spread / Average Target
+21.53%

Quarterly revenue - Rate of surprise